This is a preview of subscription content, log in via an institution to check access.
References
Marshall RP (2003) The pulmonary renin-angiotensin system. Curr Pharm Des 9(9):715–722
Zambelli V, Bellani G, Borsa R et al (2015) Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental acute respiratory distress syndrome. Intensive Care Med Exp 3:8
Imai Y, Kuba K, Rao S et al (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436(7047):112–116
The ARDS Definition Task Force (2012) Acute respiratory distress syndrome. JAMA 307(23):2526–2533
Wösten-van Asperen RM, Lutter R, Specht PA et al (2011) Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J Pathol 225(4):618–627
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare they have no conflicts of interest related to this manuscript.
Ethical approval
The Institutional Ethics Committee approved the study (protocol number 2013/269).
Informed consent
Written informed consent was obtained from the patient or the patient’s representative or next of kin.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Annoni, F., Orbegozo, D., Rahmania, L. et al. Angiotensin-converting enzymes in acute respiratory distress syndrome. Intensive Care Med 45, 1159–1160 (2019). https://doi.org/10.1007/s00134-019-05600-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-019-05600-6